Tp53 codon-72 polymorphisms identify different radiation sensitivities to g2-chromosome breakage in human lymphoblast cells

Environmental and Molecular Mutagenesis

Volumn 52, Issue 1, 2011, Pages 77-80

  Schwartz, Jeffrey L ^a   Plotnik, David ^a   Slovic, Jana ^a   Li, Tiffany ^a   Racelis, Maximillian ^a   Joachim Deeg, H ^a,b   Friedman, Debra L ^c  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b USA   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer susceptibility; G2 chromosome radiosensitivity assay; TP53 codon 72 polymorphisms

Indexed keywords

ARGININE; PROLINE;

ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE G2 PHASE; CELLULAR DISTRIBUTION; CHROMATID; CHROMOSOME BREAKAGE; CODON; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; LYMPHOBLAST; RADIOSENSITIVITY;

CELLS, CULTURED; CESIUM RADIOISOTOPES; CHROMOSOME BREAKAGE; CODON; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; POLYMORPHISM, GENETIC; RADIATION TOLERANCE;

HUMAN HERPESVIRUS 4;

EID: 78651101130     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20635     Document Type: Article

References (29)

1. Baria K, Warren C, Roberts SA, West CM, Scott D. 2001. Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer 84: 892-896.
2. Berwick M, Vineis P. 2000. Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J Natl Cancer Inst 92: 874-897.
3. Daugherty CL, Curtis H, Realini T, Charlton JF, Zareparsi S. 2009. Primary open angle glaucoma in a Caucasian population is associated with the p53 codon 72 polymorphism. Mol Vis 15: 1939-1944.
4. Dumont P, Leu JI, Della Pietra ACIII, George DL, Murphy M. 2003. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
5. el-Deiry WS. 1998. Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357.
6. Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K. 2010. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. Int J Radiat Oncol Biol Phys 76: 1199-1205.
7. Goode EL, Ulrich CM, Potter JD. 2002. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530.
8. Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN, Mori De Santiago M, Fernandez Perez L. 2009. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study. Oncol Rep 22: 1425-1433.
9. Hu Z, Li X, Yuan R, Ring BZ, Su L. 2009. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat 120: 705-714.
10. Joerger AC, Fersht AR. 2008. Structural biology of the tumor suppressor p53. Annu Rev Biochem 77: 557-582.
11. Lang A, Palmeback Wegman P, Wingren S. 2009. The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer. Oncol Rep 22: 575-579.
12. Levine AJ. 1990. Tumor suppressor genes. Bioessays 12: 60-66.
13. Li C, Wang LE, Wei Q. 2009. DNA repair phenotype and cancer susceptibility-A mini review. Int J Cancer 124: 999-1007.
14. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. 1987. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963.
15. Parshad R, Sanford KK, Jones GM, Tarone RE. 1985. G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 142: 163-168.
16. Pim D, Banks L. 2004. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108: 196-199.
17. Price FM, Parshad R, Tarone RE, Sanford KK. 1991. Radiation-induced chromatid aberrations in Cockayne syndrome and xeroderma pigmentosum group C fibroblasts in relation to cancer predisposition. Cancer Genet Cytogenet 57: 1-10.
18. Riley T, Sontag E, Chen P, Levine A. 2008. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
19. Sanford KK, Parshad R. 1999. The contribution of deficient DNA repair to chromosomal radiosensitivity of CHO cells after G2 irradiation. Cancer Genet Cytogenet 108: 38-41.
20. Sanford KK, Parshad R, Gantt RR, Tarone RE. 1989. A deficiency in chromatin repair, genetic instability, and predisposition to cancer. Crit Rev Oncog 1: 323-341.
21. Sanford KK, Parshad R, Price FM, Tarone RE, Benedict WF. 1996. Cytogenetic responses to G2 phase x-irradiation of cells from retinoblastoma patients. Cancer Genet Cytogenet 88: 43-48.
22. Schwartz JL, Giovanazzi SM, Karrison T, Jones C, Grdina DJ. 1988. 2-[(Aminopropyl)amino] ethanethiol-mediated reductions in 60Co gamma-ray and fission-spectrum neutron-induced chromosome damage in V79 cells. Radiat Res 113: 145-154.
23. Scott D. 2004. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104: 365-370.
24. Sherr CJ. 2004. Principles of tumor suppression. Cell 116: 235-246.
25. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. 2004. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23: 3328-3337.
26. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10: 789-799.
27. Zhang Z, Wang M, Wu D, Tong N, Tian Y. 2009. P53 codon 72 polymorphism contributes to breast cancer risk: A meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 120: 509-517.
28. Zhao H, Spitz MR, Tomlinson GE, Zhang H, Minna JD, Wu X. 2001. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res 61: 7819-7824.
29. Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z. 2009. Polymorphisms of TP53 codon 72 with breast carcinoma risk: Evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res 28: 115.